Cargando…
Prognostic model for overall survival that includes the combination of platelet count and neutrophil–lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma
BACKGROUND: The association between the combination of platelet count and neutrophil–lymphocyte ratio (COP-NLR) at the time of adverse events during sunitinib treatment and prognosis is unclear, and prognostic models combining the prognostic factors of sunitinib have not been well studied. Thus, we...
Autores principales: | Sato, Miki Takenaka, Ida, Ayuki, Kanda, Yuki, Takano, Kaori, Ohbayashi, Masayuki, Kohyama, Noriko, Morita, Jun, Fuji, Kohzo, Sasaki, Haruaki, Ogawa, Yoshio, Kogo, Mari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700994/ https://www.ncbi.nlm.nih.gov/pubmed/36434552 http://dx.doi.org/10.1186/s12885-022-10316-w |
Ejemplares similares
-
Scoring Model to Predict a Low Disease Activity in Elderly Rheumatoid Arthritis Patients Initially Treated with Biological Disease-modifying Antirheumatic Drugs
por: Okada, Takahiro, et al.
Publicado: (2021) -
Population Pharmacokinetic Model and Dosing Simulation of Meropenem Using Measured Creatinine Clearance for Patients with Sepsis
por: Fukumoto, Shiori, et al.
Publicado: (2023) -
Development of a Highly Sensitive Technique for Capturing Renal Cell Cancer Circulating Tumor Cells
por: Naoe, Michio, et al.
Publicado: (2019) -
PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib-Treated Patients With GIST
por: Hansson, E K, et al.
Publicado: (2013) -
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
por: Xu, C-F, et al.
Publicado: (2015)